Analysts' Upgrades and Downgrades
Thursday's Analysts' Upgrades and Downgrades
TSC Staff
01/11/07 - 10:27 AM EST
CHANGE IN RATINGS
Arbitron (ARB Quote) upgraded at Bear:
ARB was upgraded from Peer Perform to Outperform at Bear Stearns. Company is making progress in its PPM rollout, which should help drive the stock.
CACI International (CAI Quote) downgraded at Wachovia:
CAI was downgraded to Market Perform at Wachovia. Sudden departure of the CFO increases concern about the company's near-term direction.
Gol Airlines (GOL Quote) coverage resumed at Morgan Stanley:
Morgan Stanley resumes coverage of Gol Airlines with an overweight rating and a $37 price target.
Level 3 (LVLT Quote) rated new Outperform at Credit Suisse:
Credit Suisse is initiating coverage on LVLT with an Outperform rating. Believes company will continue to see strong demand driven by higher data usage. Sets $7.50 target price.
MetLife (MET Quote) upgraded at UBS:
MET upgraded to Buy rating from Neutral at UBS. Price target lifts to $71 from $64. 2007 eps estimates bumps to $5.27 from $5.23.
Tidewater (TDW Quote) coverage initiated at Goldman Sachs:
Goldman is initiating coverage on TDW with a Sell rating. See lower utilization and declining dayrates for company's old fleet. Price target at $43.
United Surgical (USPI Quote) downgraded at Deutsche:
USPI was downgraded from Buy to Hold at Deutsche Bank. $31 price target. Do not expect the company to receive a better takeover offer before next month.
STOCK COMMENTS / EPS CHANGES
Boeing (BA Quote) numbers raised at UBS:
BA numbers raised at UBS. Price target jumps to $82 from $76. 2007 eps estimates lift to $4.85 from $4.80. Reiterates Reduce rating.
Conoco Phillips (COP Quote) price target cut at Goldman:
Goldman is cutting its target on COP to $76 from $83 after company reported disappointing year-end reserve data. Believe data supports long-term strength in oil prices, and that Conoco fundamentals remain strong. Maintain Buy rating.
Genentech (DNA Quote) price target raised at Goldman:
Goldman is upping its target on DNA to $102 from $95 due to strong sales of Lucentis, Rituxan and Avastin. Company guidance was above both Goldman and consensus estimates. Maintained Buy rating.
Guitar Center (GTRC Quote) estimates cut at Piper:
Piper is cutting its 2007 estimates on GTRC to $2.74 a share due to lower expectations for top-line growth following weak Q4 sales. Maintained Outperform rating.
j2 Global (JCOM Quote) numbers lowered:
JCOM numbers lowered at Jefferies. Price target drops to $27 from $28. 2007 eps estimates lowered to $1.50 from $1.57. Reiterates Hold rating.
Urban Outfitters (URBN Quote) numbers raised at Piper:
Piper is raising its target price on URBN from $17 to $28 to reflect improved earnings outlook. Maintained Market Perform rating.
Waters (WAT Quote)numbers raised at UBS:
WAT numbers raised at UBS. Price target jumps to $57 from $52. 2007 eps estimates lift to $2.60 from $2.54. Reiterates Neutral rating.
